The Food and Drug Administration (FDA) has approved a nasal spray flu vaccine, FluMist, that consumers aged 2 to 49  will be ...
There’s good news for those who are short on time when it comes to getting a flu shot. The FDA has approved the first ...
The U.S. Food and Drug Administration has approved FluMist — the nasal spray flu vaccine — for home use by a patient or adult ...
The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self-administered ...
What to know about the "optimal time" to get vaccinated against the flu — and how the FluMist nasal spray stacks up to the traditional shot.
The FDA stated in a release on Friday, "FluMist is approved for the prevention of influenza disease caused by influenza virus ...
The spray could be an alternative for people who are averse to getting injections, or otherwise find it difficult or ...
· FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider. · FluMist ...
The FluMist vaccine can now be self-administered after the FDA approved its use to treat the influenza disease.
A nasal spray flu vaccine for people up to 49 will be available for home use starting in the fall of 2025 after the Food and ...
FluMist is the first vaccine to prevent influenza, more commonly known as the flu, that does not need to be administered by a ...
The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in 2003 for individuals between five and 49 years of age. Its approval has ...